Thomson ReutersFile photo of William Ackman, founder and CEO of hedge fund Pershing Square Capital Management, speaking during the Sohn Investment Conference in New York
BOSTON (Reuters) – Billionaire investor William Ackman’s Pershing Square Holdings, Ltd fund lost 7.1 percent last month, hurt largely by Valeant Pharmaceuticals’ roughly 60 percent tumble in March.March’s poor performance leaves Ackman’s fund with a 25.6 percent loss for the year, a person familiar with its returns said on Friday. This marks a dramatic turnaround from Pershing Square’s 40 percent gain in 2014.
Pershing Square owns a 9 percent stake in Valeant and the company’s stock tumbled last month when it cut its financial forecasts and said it could face default if it fails to file its annual report by the end of April. Last week the company’s chief executive officer agreed to step down and Ackman formally joined the board.
(Reporting by Svea Herbst-Bayliss; Editing by Chris Reese)
Read the original article on Reuters. Copyright 2016. Follow Reuters on Twitter.
More from Reuters:
- As Ebola flares up, Guinea plans to vaccinate contacts of survivors
- Swatch’s Hayek says watch industry is not in crisis: paper
- Britain’s Cameron urges talks on steel crisis with China at G20
- Austria wants to deploy soldiers on Italy border, defense minister says
- India’s ITC says to keep cigarette factories shut over health warning rules